NCT01210768 arm group 6907b8692fb04b36ab78f1238a876284 [clinicaltrials_resource:NCT01210768/arm-group/6907b8692fb04b36ab78f1238a876284]
NCT01210768 arm group 6907b8692fb04b36ab78f1238a876284 [clinicaltrials_resource:NCT01210768/arm-group/6907b8692fb04b36ab78f1238a876284]
Bio2RDF identifier
NCT01210768/arm-group/6907b8692fb04b36ab78f1238a876284
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltri ...... 07b8692fb04b36ab78f1238a876284
description [clinicaltrials_vocabulary:description]
liposomal doxorubicin, 37.5 mg/m2 q3wk, and Cyclophosphamide,600 mg/m2 q3wk
identifier
clinicaltrials_resource:NCT01210768/arm-group/6907b8692fb04b36ab78f1238a876284
title
NCT01210768 arm group 6907b8692fb04b36ab78f1238a876284
@en
type
label
NCT01210768 arm group 6907b869 ...... 7b8692fb04b36ab78f1238a876284]
@en